Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,212,537
+$39,131,922 QoQ
Shares Held
1,109,982
+189.7% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#53
of 1,348 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2026CallValue
$9,132,570
CallShares
190,500
PutValue
$10,359,834
PutShares
216,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $847,064,370 across 13 Drug Manufacturers - General names. NVO ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
151,950 | $182,253,403 | |
| 2 | ABBV |
AbbVie Inc.
|
622,946 | $156,758,131 | |
| 3 | JNJ |
Johnson & Johnson
|
584,500 | $148,445,465 | |
| 4 | SNY |
Sanofi
|
2,405,640 | $102,624,602 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
587,082 | $74,171,939 | |
| 6 | BIIB |
Biogen Inc.
|
265,090 | $57,275,345 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
1,109,982 | $53,212,537 | |
| 8 | OGN |
Organon & Co.
|
2,196,642 | $29,742,532 |
All Filings in NVO
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,212,537 | 1,109,982 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $10,359,834 | 216,100 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $9,132,570 | 190,500 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $10,911,075 | 296,900 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $14,080,615 | 383,146 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $21,811,125 | 593,500 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $3,917,760 | 77,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $2,900,160 | 57,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $25,852,585 | 508,109 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,440,450 | 43,980 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $4,661,160 | 84,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $19,787,734 | 356,600 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $12,340,776 | 178,800 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $289,884 | 4,200 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $105,928,514 | 1,534,751 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,180,032 | 117,800 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $1,729,056 | 24,900 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $21,346,480 | 307,409 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $43,018,602 | 500,100 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $240,856 | 2,800 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $62,580,754 | 727,514 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $62,546,399 | 525,291 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $54,761,344 | 383,644 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $22,965,900 | 222,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $31,035,000 | 300,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $41,759,971 | 403,673 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $53,199,900 | 585,000 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $14,726,530 | 91,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $16,637,927 | 104,549 | Shares | Sole | 2023-05-15 | |
| 2021-06-30 | $15,673,031 | 187,096 | Shares | Sole | 2021-08-16 | |
| 2021-06-30 | $10,890,100 | 130,000 | Call | Sole | 2021-08-16 | |
| 2020-06-30 | $23,756,667 | 362,808 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $28,127,125 | 467,228 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||